NCT04248439Phase 2Active not recruiting

Gene Therapy for Fanconi Anemia, Complementation Group A

Study sponsor: Rocket Pharmaceuticals Inc. · RCKT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-05-05Estimated
Enrollment · participants5Estimated
Source updated2025-12-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: May 2026. After: 5 May 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview